Most importantly, they also revealed that KNK437 combined with Oxaliplatin/5-fluorouracil/leucovorin showed a synergistic inhibitive effect on DnaJA1-mediated liver metastasis, suggesting KNK437 as an alternative approach for the CRC treatment [21]. Here, DNAJA1 is linked to colorectal carcinoma.